Tyor WR - Search Results

1

The Janus kinase inhibitor ruxolitinib reduces HIV replication in human macrophages and ameliorates HIV encephalitis in a murine model.

Haile WB, Gavegnano C, Tao S, Jiang Y, Schinazi RF, Tyor WR. Haile WB, et al. Among authors: tyor wr. Neurobiol Dis. 2016 Aug;92(Pt B):137-43. doi: 10.1016/j.nbd.2016.02.007. Epub 2016 Feb 3. Neurobiol Dis. 2016. PMID: 26851503 Free PMC article.

2

Morphine exposure during HIV encephalitis in SCID mice.

Tyor WR, Hwang HY, Fritz-French C. Tyor WR, et al. Neurochem Res. 2012 Dec;37(12):2836-41. doi: 10.1007/s11064-012-0877-z. Epub 2012 Sep 11. Neurochem Res. 2012. PMID: 22965853 Free PMC article.

3

Combined antiretroviral therapy reduces brain viral load and pathological features of HIV encephalitis in a mouse model.

Koneru R, Olive MF, Tyor WR. Koneru R, et al. Among authors: tyor wr. J Neurovirol. 2014 Feb;20(1):9-17. doi: 10.1007/s13365-013-0223-5. Epub 2014 Jan 11. J Neurovirol. 2014. PMID: 24415129

4

The recombinant vaccinia virus gene product, B18R, neutralizes interferon alpha and alleviates histopathological complications in an HIV encephalitis mouse model.

Fritz-French C, Shawahna R, Ward JE, Maroun LE, Tyor WR. Fritz-French C, et al. Among authors: tyor wr. J Interferon Cytokine Res. 2014 Jul;34(7):510-7. doi: 10.1089/jir.2013.0072. Epub 2014 Feb 24. J Interferon Cytokine Res. 2014. PMID: 24564363 Free PMC article.

5

HIV latency reversal research and the potential effects on the central nervous system: is concern warranted?

Anderson AM, Schinazi RF, Tyor WR. Anderson AM, et al. Among authors: tyor wr. J Int AIDS Soc. 2016 May 9;19(1):21008. doi: 10.7448/IAS.19.1.21008. eCollection 2016. J Int AIDS Soc. 2016. PMID: 27166355 Free PMC article. No abstract available.

6

Reversing interferon-alpha neurotoxicity in a HIV-associated neurocognitive disorder mouse model.

Koneru R, Bimonte-Nelson H, Ciavatta V, Haile W, Elmore K, Ward J, Maroun L, Tyor WR. Koneru R, et al. Among authors: tyor wr. AIDS. 2018 Jul 17;32(11):1403-1411. doi: 10.1097/QAD.0000000000001836. AIDS. 2018. PMID: 29683852

7

Baricitinib reverses HIV-associated neurocognitive disorders in a SCID mouse model and reservoir seeding in vitro.

Gavegnano C, Haile WB, Hurwitz S, Tao S, Jiang Y, Schinazi RF, Tyor WR. Gavegnano C, et al. Among authors: tyor wr. J Neuroinflammation. 2019 Sep 27;16(1):182. doi: 10.1186/s12974-019-1565-6. J Neuroinflammation. 2019. PMID: 31561750 Free PMC article.

8

Novel method to quantify phenotypic markers of HIV-associated neurocognitive disorder in a murine SCID model.

Gavegnano C, Haile W, Koneru R, Hurwitz SJ, Kohler JJ, Tyor WR, Schinazi RF. Gavegnano C, et al. Among authors: tyor wr. J Neurovirol. 2020 Dec;26(6):838-845. doi: 10.1007/s13365-020-00842-3. Epub 2020 Sep 8. J Neurovirol. 2020. PMID: 32901392 Free PMC article.

9

A Rationale and Approach to the Development of Specific Treatments for HIV Associated Neurocognitive Impairment.

Scanlan A, Zhang Z, Koneru R, Reece M, Gavegnano C, Anderson AM, Tyor W. Scanlan A, et al. Microorganisms. 2022 Nov 12;10(11):2244. doi: 10.3390/microorganisms10112244. Microorganisms. 2022. PMID: 36422314 Free PMC article. Review.

10

SCID mice with HIV encephalitis develop behavioral abnormalities.

Avgeropoulos N, Kelley B, Middaugh L, Arrigo S, Persidsky Y, Gendelman HE, Tyor WR. Avgeropoulos N, et al. Among authors: tyor wr. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 May 1;18(1):13-20. doi: 10.1097/00042560-199805010-00003. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9593453

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters